Debt instrument, exit fee Debt Instrument, Exit Fee Debt Instrument, Exit Fee Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Shares of common stock in connection with securities purchase agreements (in shares) Shares Of Common Stock To Be Purchased By Common Stock Warrants Shares of Common Stock to be Purchased by Common Stock Warrants Statistical Measurement [Domain] Statistical Measurement [Domain] Revenue share payments thereafter Collaborative Arrangement, Estimated Revenue Share Payments upon Purchaser’s Receipt, Thereafter Collaborative Arrangement, Estimated Revenue Share Payments upon Purchaser’s Receipt, Thereafter Interest income and other income, net Interest And Other Income, Net Interest And Other Income, Net Award Timing Predetermined Award Timing Predetermined [Flag] Remainder of 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Vesting Condition [Domain] Vesting Condition [Domain] Market Conditions [Domain] Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Payments for loan acquisition costs Payments of Financing Costs Tabular List, Table Tabular List [Table Text Block] Exercise of warrants (in shares) Class of Warrant or Right, Warrants Exercised The number of class of warrant or right exercised. Leases [Abstract] Leases [Abstract] Royalty receivable Cumulative Royalty Receivable Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date. Number of guaranteed royalty payments Number Of Guaranteed Royalty Payments Number Of Guaranteed Royalty Payments Intangible Asset, Acquired, Finite-Lived [Line Items] Intangible Asset, Acquired, Finite-Lived [Line Items] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable Share-based Compensation expenses [Abstract] Share-Based Payment Arrangement, Noncash Expense [Abstract] Schedule of Royalty Obligation Royalty Obligation Activity [Table Text Block] Royalty Obligation Activity Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Class of warrant or right, outstanding (in shares) Class of Warrant or Right, Outstanding Basic (in dollars per share) Loss per common share – basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Market Condition Range Two Market Condition Range Two [Member] Market Condition Range Two Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Public Equity Offering - ATM At-the-market offering At The Market Offering [Member] At The Market Offering Revenues and Trade Receivables, Net Revenue from Contract with Customer [Text Block] Computer, network equipment and software Computer, Network Equipment and Software [Member] Assets which are related to computer, network equipment and software. Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Vested restricted stock units, net (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Costs associated with public offering-ATM in Accounts Payable Costs Associated with At-the-Market Public Equity Offering in Accounts Payable Costs Associated with At-the-Market Public Equity Offering in Accounts Payable Measurement Input Type [Domain] Measurement Input Type [Domain] Other Other Assets, Miscellaneous, Noncurrent Proceeds from common stock issued under public equity offering-ATM, net Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises 2030 and thereafter Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentrations of risk (as a percent) Concentration Risk, Percentage Unamortized deferred debt issuance cost and deferred debt discounts Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Notes payable, current Notes and Loans Payable, Current Share-based compensation Share-Based Payment Arrangement, Noncash Expense Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Underwritten Public Offering Underwritten Public Offering [Member] Underwritten Public Offering Stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounts and Financing Receivables [Table] Accounts and Financing Receivables [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders’ deficit Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Share-based compensation expenses Share-Based Payment Arrangement, Expense Market Conditions [Domain] Market Conditions [Domain] Market Conditions [Domain] Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Indivior Indivior [Member] Indivior Common Stock issued under public equity offering-ATM (in shares) Stock Issued During Period, Shares, New Issues Current assets: Assets, Current [Abstract] Total liabilities and stockholders’ deficit Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Liabilities and stockholders’ deficit Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Valuation Technique, Black-Scholes-Merton Model Valuation Technique, Black-Scholes-Merton Model [Member] Liability related to the sale of future revenue, net at beginning of the period Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively) Liabilities, Sale of Future Royalties Liabilities, Sale of Future Royalties Debt Covenant, Redemption Scenario [Axis] Debt Covenant, Redemption Scenario [Axis] Debt Covenant, Redemption Scenario Maximum Maximum [Member] Selling, general and administrative General and Administrative Expense [Member] Royalty interest percent interest (as a percent) Royalty Obligation, Percent Of Net Sales Royalty Obligation, Percent Of Net Sales Accounting Policies [Abstract] Accounting Policies [Abstract] Schedule of Operating Lease Liabilities Maturities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Risks and Uncertainties Concentration Risk Disclosure [Text Block] Number of annual royalty payments receivable Number of Annual Royalty Payments Receivable Number of annual royalty payments receivable by the entity for the use of its rights and property by another party. Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating lease liabilities Operating Lease, Liability Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Warrants issued to purchase common stock (in shares) Class Of Warrant Or Right Warrants Issued During Period The number of warrants issued during the period. Depreciation, amortization, and impairment Depreciation, Depletion and Amortization, Nonproduction Net loss before income taxes Net (loss)/income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Debt instrument, redemption price, percentage of principal amount redeemed (as a percent) Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Other non-current liabilities Other Liabilities, Noncurrent Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Deferred revenue Increase (Decrease) in Deferred Revenue Proceeds from Issuance of Debt Proceeds from Issuance of Debt ABL Facility ABL Facility [Member] ABL Facility Automatic renewal period of agreement (in years) Automatic Renewal Period of Agreement Period for which the agreement is renewed automatically. Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Remaining lease term (in years) Lessee, Operating Lease, Remaining Lease Term Market Condition Range Five Market Condition Range Five [Member] Market Condition Range Five Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Expected to vest at end of period (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date. Line of Credit Facility [Table] Line of Credit Facility [Table] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Measurement Input Type [Axis] Measurement Input Type [Axis] Name Measure Name Fair value of warrants issued Adjustments to Additional Paid in Capital, Fair Value of Warrants Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of fair value of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Lease liabilities, current Operating Lease, Liability, Current Document Fiscal Period Focus Document Fiscal Period Focus Less: sales-related allowances Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification Unsecured Debt Unsecured Debt [Member] Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] Furniture and fixtures Furniture and Fixtures [Member] Award Type [Axis] Award Type [Axis] Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent Total Long-Term Debt Total assets Assets Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] 2020 Additional Notes 2020 Additional Notes [Member] 2020 Additional Notes Trading Symbol Trading Symbol Vesting Condition Range Eight Vesting Condition Range Eight [Member] Vesting Condition Range Eight Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Royalty rights agreement, measurement input (as a percent) Royalty Agreement, Measurement Input Royalty Agreement, Measurement Input Commercial exploitation agreement with Indivior Commercial Exploitation Agreement with Indivior [Member] The commercial exploitation agreement with Indivior. Geographical [Domain] Geographical [Domain] Amended Equity Distribution Agreement Amended Equity Distribution Agreement [Member] Amended Equity Distribution Agreement Entity Address, City or Town Entity Address, City or Town Operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Receivable Type [Axis] Receivable Type [Axis] Company Overview and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Asset Retirement Obligation, Roll Forward Analysis [Roll Forward] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Inventories, Net Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Restricted stock units Restricted Stock Units (RSUs) [Member] Number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Warrants on common shares outstanding Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Capitalized contract cost, net Capitalized Contract Cost, Net Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Debt issuance costs, net Debt Issuance Costs, Net Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Number of equity instruments Debt Instrument, Convertible, Number of Equity Instruments Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Provision Accounts Receivable, Credit Loss Expense (Reversal) Line of credit facility, accordion feature, net revenue threshold Line of Credit Facility, Accordion Feature, Net Revenue Threshold Line of Credit Facility, Accordion Feature, Net Revenue Threshold Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Proprietary product revenue, net Proprietary Product Revenue [Member] The aggregate revenue generated from proprietary product sales. Number of cases pending Loss Contingency, Pending Claims, Number Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Redemption Scenario 1 Redemption Scenario 1 [Member] Redemption Scenario 1 Royalty obligation, term (in years) Debt Instrument, Covenant, Tiered Royalty Percentage, Term Debt Instrument, Covenant, Tiered Royalty Percentage, Term United States UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] License and royalty revenue a License and Royalty Revenue [Member] The aggregate revenue generated from licensing and royalties. Options exercised, net Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Liability related to the sale of future revenue, net Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Effective annual interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Manufacture and supply revenue Manufacture and Supply Revenue [Member] The aggregate revenue generated from manufacture and supply. Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income taxes (benefit) expense Income Tax Expense (Benefit) Sale of Stock [Domain] Sale of Stock [Domain] Real estate and personal property taxes Taxes Payable, Current Doubtful Accounts Trade Accounts Receivable, Doubtful Accounts [Member] Trade Accounts Receivable, Doubtful Accounts Debt Instrument, Milestone Tranches [Axis] Debt Instrument, Milestone Tranches [Axis] Debt Instrument, Milestone Tranches Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] 13.5% Senior Secured Notes due November 1, 2028 Senior Secured Notes, 13.5% due November 1, 2028 [Member] Senior Secured Notes, 13.5% due November 1, 2028 Product and Service [Domain] Product and Service [Domain] Customer concentration risk Customer Concentration Risk [Member] Exercisable at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Property and equipment, gross Property, Plant and Equipment, Gross Asset Retirement Obligation Disclosure [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Additions Asset Retirement Obligation, Liabilities Incurred Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from exercise of stock options, net Proceeds from Stock Options Exercised Research and development, project duration (in years) Research and Development, Project Duration Research and Development, Project Duration City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Proceeds from collaborators Proceeds from Collaborators All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Repurchase price (as a percent) Debt Instrument, Redemption Price, Percentage Interest expense related to the sale of future revenue Interest Expense, Sale of Future Revenues Interest Expense, Sale of Future Revenues Accrued expenses Total accrued expenses Accrued Liabilities, Current Reclassification into Accrued distribution expenses and sales-related allowances Accounts Receivable, Allowance for Credit Loss, Reclassifications Accounts Receivable, Allowance for Credit Loss, Reclassifications Minimum annual royalty receivable Minimum Annual Royalty Receivable Minimum annual royalty receivable by the entity for the use of its rights and property by another party. Unvested, at beginning of period (in shares) Unvested, at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Total General and Administrative Expenses General and Administrative Expense Reportable Segment Reportable Segment [Member] Reportable Segment Investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Unrecognized compensation expense related to non-vested stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used for operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Debt instrument, term (in years) Debt Instrument, Term Useful Lives Property, Plant and Equipment, Useful Life Subsequent event Subsequent Event [Member] Schedule of Stock Option Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Vesting Condition Range Ten Vesting Condition Range Ten [Member] Vesting Condition Range Ten Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Depreciation Depreciation Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Vested or expected to vest at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price License & Supply Agreement License & Supply Agreement [Member] License & Supply Agreement Equity Components [Axis] Equity Components [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Ex-United States Non-US [Member] Warrants Warrants Disclosure [Text Block] The entire disclosure for warrants. Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Trade Accounts Receivable Trade Accounts Receivable [Member] Concentration Risk [Table] Concentration Risk [Table] Number of reportable segments Number of Reportable Segments Unamortized discount (premium), net Debt Instrument, Unamortized Discount (Premium), Net Vesting period (in years) Warrants and Rights Outstanding, Term Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Total current liabilities Liabilities, Current Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Average closing prices period (in days) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period Sale of Future Revenue [Roll Forward] Sale of Future Revenue [Roll Forward] Sale of Future Revenue Individual: Individual [Axis] Schedule of Liability for Asset Retirement Obligations Schedule of Asset Retirement Obligations [Table Text Block] License agreement term (in years) License Agreement Term License agreement term period. Research and development Research and Development Expense [Member] Initial rent abatement period Lessee, Operating Lease, Initial Rent Abatement Period Lessee, Operating Lease, Initial Rent Abatement Period Net cash used for investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Cash payments for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Right-of-use assets, net Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Royalty Obligations Royalty Obligations [Member] Royalty Obligations Operating lease expense Operating Lease, Cost Plan Name [Domain] Plan Name [Domain] Unrecognized compensation cost, recognition period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Options exercises, net (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Revenue Recognition and Performance Obligations Revenue from Contract with Customer [Policy Text Block] Market Condition Range Four Market Condition Range Four [Member] Market Condition Range Four MAM Pangolin Royalty , LLC Marathon Pangolin Royalty LLC [Member] Marathon Pangolin Royalty LLC Segment Reporting Segment Reporting Disclosure [Text Block] Vesting Condition Range Nine Vesting Condition Range Nine [Member] Vesting Condition Range Nine Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] RTW Investments LP RTW Investments LP [Member] RTW Investments LP Other Receivables And Accrued Expenses Other Receivables And Accrued Expenses [Member] Other Receivables And Accrued Expenses Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Forfeited/expired (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period Weighted Average Exercise Price Weighted average price of options that were either exercised, forfeited or expired. Selling, general and administrative Total Selling, General and Administrative Expenses Selling, General and Administrative Expense Other non-current assets Total other non-current assets Other Assets, Noncurrent Interest payable Interest Payable, Current Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key License agreement with Sunovion Pharmaceuticals, Inc. upfront License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member] The license agreement made with sunovion pharmaceuticals, inc. advance payments. PEO Name PEO Name Costs and expenses: Cost of Product and Service Sold [Abstract] Asset retirement obligation Balance at beginning of period Balance at ending of period Asset Retirement Obligation Aggregate payment Revenues Schedule of Debt Maturities Schedule of Maturities of Long-Term Debt [Table Text Block] Consideration received on sale of stock Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Finished goods Inventory, Finished Goods, Gross Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Senior secured notes due 2025 Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member] A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer. Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Deferred revenue, current Contract with Customer, Liability, Current Number of leases Number of Operating Leases Number of operating leases. Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Segments [Axis] Segments [Axis] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Debt Instrument, Milestone Tranches [Domain] Debt Instrument, Milestone Tranches [Domain] Debt Instrument, Milestone Tranches [Domain] Exercise Price Award Exercise Price Market Based Market Based [Member] Market Based Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized compensation costs of RSU awards Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Stock price at grant date Share Price Subsequent Event Type [Axis] Subsequent Event Type [Axis] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Notes payable, long-term Long-Term Debt, Excluding Current Maturities Credit Facility [Axis] Credit Facility [Axis] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Cash and cash equivalents: Restricted Cash and Cash Equivalent [Abstract] Vesting Condition [Axis] Vesting Condition [Axis] Vesting Condition Debt Instrument [Axis] Debt Instrument [Axis] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Financial Instruments – Fair Value Measurements Fair Value Disclosures [Text Block] Credit Facility [Domain] Credit Facility [Domain] Stockholders’ deficit: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Award vesting rights (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Entity Address, Address Line One Entity Address, Address Line One Trade Accounts Receivable, Sales Related Trade Accounts Receivable, Sales Related [Member] Trade Accounts Receivable, Sales Related Research and development Total Research and Development Expenses Research and Development Expense Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Schedule of Revenue Revenue from External Customers by Products and Services [Table Text Block] Lease liabilities Operating Lease, Liability, Noncurrent Debt Covenant, Redemption Scenario [Domain] Debt Covenant, Redemption Scenario [Domain] Debt Covenant, Redemption Scenario [Domain] Interest expense related to royalty obligations Royalty Expense Vesting Condition Range Twelve Vesting Condition Range Twelve [Member] Vesting Condition Range Twelve Fair Value as of Grant Date Award Grant Date Fair Value Sale of Stock, Shares Committed, Aggregate Amount Sale of Stock, Shares Committed, Aggregate Amount Sale of Stock, Shares Committed, Aggregate Amount Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Royalty Obligations, Gross Royalty Obligations, Gross Royalty Obligations, Gross Proceeds from warrant exercises Proceeds from Warrant Exercises Estimated discount rate (as a percent) Lessee, Operating Lease, Discount Rate Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Schedule of Term Notes and Unamortized Debt Discount Balances Schedule of Long-Term Debt Instruments [Table Text Block] Revenue share payments year ten Collaborative Arrangement, Estimated Revenue Share Payments Upon Purchaser’s Receipt, Year Ten Estimated Revenue Share Payments Upon Purchaser’s Receipt, Year Ten Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total costs and expenses Costs and Expenses Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Manufacture and supply Manufacturing And Supply [Member] Primary financial statement caption encompassing Manufacturing and supply expense. Document Quarterly Report Document Quarterly Report Costs of common stock issued under public equity offering-ATM Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Fair value Long-Term Debt, Fair Value Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Selling expenses: Selling, General and Administrative Expense [Abstract] Counterparty Name [Domain] Counterparty Name [Domain] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Number of operating segments Number of Operating Segments Cost, Product and Service [Extensible Enumeration] Cost, Product and Service [Extensible Enumeration] Market Condition Range One Market Condition Range One [Member] Market Condition Range One Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Machinery Machinery and Equipment [Member] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Receivables Accounts Receivable [Member] Sale of Stock, Share Commitment, Period following Effective Date (in days) Sale of Stock, Share Commitment, Period following Effective Date Sale of Stock, Share Commitment, Period following Effective Date Measurement Input, Probability Of Success Measurement Input, Probability Of Success [Member] Measurement Input, Probability Of Success Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Sale of Future Revenue Sale of Future Revenue [Text Block] Sale of Future Revenue Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] Other, net Other Noncash Income (Expense) Packaging material Inventory Packing Material Gross Amount of packaging materials expected to be sold within one year or operating cycle, if longer. Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Trade and other receivables, net Increase (Decrease) in Accounts and Other Receivables Compensation Amount Outstanding Recovery Compensation Amount Principal amount Debt Instrument, Face Amount Tranche Two Tranche Two [Member] Tranche Two Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Unvested, at beginning of period (in dollars per share) Unvested, at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Other Non-current Assets Other Assets Disclosure [Text Block] Warrants issued under the Purchase Agreement Proceeds from Exercise of Warrants, Net Proceeds from Exercise of Warrants, Net Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition New Warrants New Warrants [Member] New Warrants Notes payable, net Notes payable, net Long-Term Debt and Lease Obligation 2027 Long-Term Debt, Maturity, Year One Litigation Case [Axis] Litigation Case [Axis] Zevra And Commave Therapeutics Agreement Zevra And Commave Therapeutics Agreement [Member] Zevra And Commave Therapeutics Agreement Service Based Service Based [Member] Service Based Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Performance Shares Performance Shares [Member] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Royalty Royalty [Member] Inventories Increase (Decrease) in Inventories Inventories Total inventory Inventory, Net Amortization of debt issuance costs and discounts Amortization of Debt Issuance Costs and Discounts Loans payable, current Loans Payable, Current Warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Minimum Minimum [Member] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Zevra Zevra [Member] Zevra Accretion Asset Retirement Obligation, Accretion Expense Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Company Selected Measure Name Company Selected Measure Name General & Administrative expenses: General and Administrative Expense [Abstract] Numerator: Undistributed Earnings, Basic [Abstract] Exchange for the Purchaser’s payment Consideration Receivable From Sale Of Future Revenues Interests Consideration Receivable From Sale Of Future Revenues Interests Senior Notes Senior Notes [Member] Other Non-Current Liabilities Asset Retirement Obligation Disclosure [Text Block] Long-Term Debt Debt Disclosure [Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock, $0.001 par value. Authorized $250,000,000 shares; 124,284,542 and 122,044,299 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Contingencies Commitments and Contingencies Disclosure [Text Block] Payments for royalty obligations Payments for Royalty Obligations Payments for Royalty Obligations Diluted (in shares) Weighted-average number of common shares – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Contingencies (Note 20) Commitments and Contingencies Schedule of Royalty Right Agreements Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement [Table Text Block] Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Small Business Entity Small Business Royalty payment term (in years) Royalty Obligation, Term Royalty Obligation, Term Payments for stock issuance costs Payments of Stock Issuance Costs Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Redemption Scenario 2 Redemption Scenario 2 [Member] Redemption Scenario 2 Document Transition Report Document Transition Report Underlying Securities Award Underlying Securities Amount Concentration Risk [Line Items] Concentration Risk [Line Items] Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date Average closing price, number of days utilized in pricing period (in days) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Days Utilized in Pricing Period Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Days Utilized in Pricing Period PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Allowance for credit loss Balance at beginning of period Balance at end of period Accrued distribution expenses and sales returns provision Accounts Receivable, Allowance for Credit Loss Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Revenue from Contract with Customer [Abstract] Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Amortization of debt discount (premium) Amortization of Debt Discount (Premium) License agreement with Sunovion Pharmaceuticals, Inc. License Agreement with Sunovion Pharmaceuticals, Inc. [Member] The license agreement made with sunovion pharmaceuticals, inc. Document Type Document Type Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Revenues Revenue from Contract with Customer Benchmark [Member] Variable lease expense Variable Lease, Cost Revenues Total revenues Royalties related to the sale of future revenue Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Vested or expected to vest at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Existing Warrants Existing Warrants [Member] Existing Warrants Tranche Three Tranche Three [Member] Tranche Three Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Payments for taxes on share-based compensation, net Payment, Tax Withholding, Share-Based Payment Arrangement Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Debt instrument, redemption price, basis points above treasury rate Debt Instrument, Redemption Price, Basis Spread On Variable Rate Debt Instrument, Redemption Price, Basis Spread On Variable Rate Market Conditions [Axis] Market Conditions [Axis] Market Conditions Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities: Liabilities, Current [Abstract] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Geographical [Axis] Geographical [Axis] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Co-development and research fees Co-Development and Research Fees [Member] The aggregate revenue generated from Co-development and research fees. Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Assertio Assertio Holdings, Inc Assertio Holdings, Inc [Member] Assertio Holdings, Inc Diluted (in dollars per share) Loss per common share – diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited/expired (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised, Forfeitures And Expirations In Period For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Number of pricing periods Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Pricing Periods Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Pricing Periods BRITISH COLUMBIA BRITISH COLUMBIA Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Line of credit facility, accordion feature, increase limit Line of Credit Facility, Accordion Feature, Increase Limit Line of Credit Facility, Accordion Feature, Increase Limit First Additional Warrant Offering First Additional Warrant Offering [Member] First Additional Warrant Offering Loss per share attributable to common stockholders: Earnings Per Share [Abstract] Royalty Right Agreements Royalty Right Agreements [Member] Royalty Right Agreements Equity distribution agreement Equity Distribution Agreement [Member] Equity Distribution Agreement Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Anaphylm project expenses Anaphylm [Member] Anaphylm Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Sale of stock, maximum transaction amount Sale of Stock, Maximum Transaction Amount Sale of Stock, Maximum Transaction Amount Royalty obligations, net Royalty Obligation, Liability, Noncurrent Royalty Obligation, Liability, Noncurrent Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Suboxone Produce Liability Litigation Suboxone Produce Liability Litigation [Member] Suboxone Produce Liability Litigation Schedule of Restricted Stock Units Awards Nonvested Restricted Stock Shares Activity [Table Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Award Timing Disclosures [Line Items] Tranche Four Tranche Four [Member] Tranche Four Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Total Outstanding notes/Total Royalty obligations Long-Term Debt, Gross Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Accrued compensation Employee-related Liabilities, Current Shares of common stock (in shares) Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants Payments / credits Accounts Receivable, Allowance for Credit Loss, Recovery Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Lessee, operating lease, renewal term Lessee, Operating Lease, Renewal Term Total future lease payments Lessee, Operating Lease, Liability, to be Paid Net loss Net loss Net Income (Loss) Attributable to Parent Subsequent Event [Table] Subsequent Event [Table] Expiration Date Trading Arrangement Expiration Date Purchase And Sale Agreement Purchase And Sale Agreement [Member] Purchase And Sale Agreement Construction in progress Construction in Progress [Member] Other Other Accrued Liabilities, Current Award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Common Stock Warrants Common Stock Warrants [Member] Common Stock Warrants Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Vesting Condition Range Eleven Vesting Condition Range Eleven [Member] Vesting Condition Range Eleven Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net 2025 Market Based 2025 Market Based [Member] 2025 Market Based Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Adoption Date Trading Arrangement Adoption Date Market Condition Range Six Market Condition Range Six [Member] Market Condition Range Six Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Proceeds from sale of future revenue Proceeds From Sale of Future Revenues, Net Proceeds From Sale of Future Revenues, Net Current and non-current contract assets Contract with Customer, Asset, after Allowance for Credit Loss Hypera Hypera [Member] Hypera Entity Current Reporting Status Entity Current Reporting Status Initial term Lessee, Operating Lease, Term of Contract Customer [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating Income (Loss) Line of Credit Line of Credit [Member] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Schedule of Share-Based Compensation Expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Vesting Condition Range Seven Vesting Condition Range Seven [Member] Vesting Condition Range Seven Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Repayment of debt principal including lease liabilities Repayments of debt Repayments of Debt Monetization Agreement Monetization Agreement [Member] Monetization Agreement Current Fiscal Year End Date Current Fiscal Year End Date 2022 Inducement Equity Incentive Plan 2022 Inducement Equity Incentive Plan [Member] 2022 Inducement Equity Incentive Plan Securities purchase agreement Securities Purchase Agreement [Member] Securities Purchase Agreement Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Event Type [Domain] Subsequent Event Type [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Schedule of Trade and Other Receivables, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Other income/(expenses), net Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Adjustments to reconcile net loss to net cash used for operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Material Agreements Collaborative Arrangement Disclosure [Text Block] Financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average common shares outstanding: Earnings Per Share, Basic, Other Disclosure [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Other Other [Member] Other License agreement with Sunovion Pharmaceuticals, Inc milestones License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member] The license agreement made with sunovion pharmaceuticals, inc. milestones. Market Condition Range Three Market Condition Range Three [Member] Market Condition Range Three Trade and other receivables, net Trade and other receivables, net Receivables, Net, Current Contract liabilities Contract with Customer, Liability Finance lease Finance Lease, Liability, Noncurrent Reclassification into Accrued distribution expenses and sales-related allowances Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net. Antidilutive securities excluded from computation of earnings per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Contract and other receivables Other Receivables, Gross, Current All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Price per share (in dollars per share) Sale of Stock, Price Per Share Liability related to the sale of future revenue, current Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current 2028 Long-Term Debt, Maturity, Year Two Right-of-Use Assets and Lease Obligations Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Receivable [Domain] Receivable [Domain] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Total Selling expenses Selling Expense Vested restricted stock units, net Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Basic (in shares) Weighted-average number of common shares – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Remaining authorized amount Share Repurchase Program, Remaining Authorized, Amount Manufacture and supply Total Manufacture and Supply Expenses Cost of Product and Service Sold Warrants and rights outstanding Warrants and Rights Outstanding Proceeds from debt, contingent on additional milestones Contingent Monetization Agreement, Milestone Payment Contingent Monetization Agreement, Milestone Payment Schedule of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Exercisable at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Amortization of issuance costs Amortization of Debt Issuance Costs Other income/(expenses): Nonoperating Income (Expense) [Abstract] Atnahs Pharma UK Limited Atnahs Pharma UK Limited [Member] Atnahs Pharma UK Limited Entity Tax Identification Number Entity Tax Identification Number Liability related to the sale of future revenue, current Liabilities, Sale of Future Royalties, Current Liabilities, Sale of Future Royalties, Current Trade receivables Accounts Receivable, before Allowance for Credit Loss Issuance of warrants Issuance of Stock and Warrants for Services or Claims Unamortized discount Unamortized discount, including Exit Fee Debt Instrument, Unamortized Discount Outstanding at beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Underwriting discounts Sale of Stock, Consideration Received on Transaction, Underwriting Discounts Sale of Stock, Consideration Received on Transaction, Underwriting Discounts Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Capitalized Legal Fees Capitalized Legal Fees Capitalized Legal Fees Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Performance price threshold (in dollars per share) Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Additional proceeds from sale of future revenue Additional Proceeds From Sale of Future Revenues, Net Additional Proceeds From Sale of Future Revenues, Net Total Shareholder Return Amount Total Shareholder Return Amount Schedule of Other Non-Current Assets Schedule of Other Assets, Noncurrent [Table Text Block] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name 2026 Long-Term Debt, Maturity, Remainder of Fiscal Year Raw material Inventory, Raw Materials, Gross Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Revenue sharing percentage Collaborative Arrangement, Revenue Sharing Percentage Collaborative Arrangement, Revenue Sharing Percentage Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Costs and expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Expected to vest at end of period (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, in Shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares AQST-108 project expenses AQST-108 [Member] AQST-108 Schedule of Sales-related Allowances Schedule of Accounts Receivable Allowances [Table Text Block] Schedule of Accounts Receivable Allowances Personnel costs Personnel Costs [Member] Personnel Costs Common Stock issued under public equity offering-ATM Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Sale of stock, aggregate offering price Sale of Stock, Aggregate Offering Price Sale of Stock, Aggregate Offering Price Term Loan Facility Term Loan Facility [Member] Term Loan Facility Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Potential increase in available borrowing capacity upon pre determined achievement of milestones Line Of Credit Facility, Available Borrowing Capacity, Increase Limit Line Of Credit Facility, Available Borrowing Capacity, Increase Limit Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Subsequent Event [Line Items] Subsequent Event [Line Items] Common Stock Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Depreciation expense related to ARO Asset Retirement Obligations Depreciation Expense Depreciation expense of asset retirement obligation. Non-NEOs Non-NEOs [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Atnahs Pharma UK Limited, Amended Agreement Atnahs Pharma UK Limited, Amended Agreement [Member] Atnahs Pharma UK Limited, Amended Agreement Net increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Manufactured Product, Other [Member]